Products for Research Use Only
RegisterLogin

Rilogrotug

CAT: 0804-HY-P991190-01Size: 1 mgDry Ice: YesHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-P991190-01Size:1 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Rilogrotug (AV-380) is a humanized IgG1 monoclonal antibody targeting GDF15[1].
CAS Number
2894138-72-6
Product Name Alternative
AV-380
UNSPSC
12352203
Target
TGF-beta/Smad
Related Pathways
Stem Cell/Wnt; TGF-beta/Smad
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Purity
99.9
Smiles
[Rilogrotug]
Molecular Weight
(145.71 kDa)
References & Citations
[1]Arvind Chaudhry, et al. A phase 1b dose escalation study of AV-380 in combination with standard of care chemotherapy in metastatic cancer patients (pts) with cachexia and elevated GDF-15 levels. Therapeutic Agents: Biological| December 01 2023.
Shipping Conditions
Dry Ice
Storage Conditions
-80°C
Scientific Category
Inhibitory Antibodies
Clinical Information
Phase 1

Alternative Products

CatalogName
T9901A-392-01Rilogrotug
GTR18608345-01Rilogrotug Antibody
HV986046-01Research Grade rilogrotug
A138175Rilogrotug Biosimilar (Monoclonal, IgG1)
PX-TA2443-01Rilogrotug Biosimilar - Research Grade
GTR18695450-01Rilogrotug Human Monoclonal Antibody
MBS1881645-01Anti-GDF15 (rilogrotug biosimilar) mAb
A137463Rilogrotug Biosimilar (Monoclonal, IgG1, Kappa)
12-90294B-50Biotinylated Anti-GDF15 (rilogrotug biosimilar) mAb
MBS1881647-01PE-conjugated Anti-GDF15 (rilogrotug biosimilar) mAb

Popular Products